SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the first successful internet money based on peer-to-peer technology; whereby no central bank or authority is involved in the transaction and production of the Bitcoin currency. It was created by an anonymous individual/group under the name, Satoshi Nakamoto. The source code is available publicly as an open source project, anybody can look at it and be part of the developmental process.  Bitcoin is changing the way we see money as we speak. The idea was to produce a means of exchange, independent of any central authority, that could be transferred electronically in a secure, verifiable and immutable way. It is a decentralized peer-to-peer internet currency making mobile payment easy, very low transaction fees, protects your identity, and it works anywhere all the time with no central authority and banks.  Bitcoin is designed to have only 21 million BTC ever created, thus making it a deflationary currency. Bitcoin uses the SHA-256 hashing algorithm with an average transaction confirmation time of 10 minutes. Miners today are mining Bitcoin using ASIC chip dedicated to only mining Bitcoin, and the hash rate has shot up to peta hashes.  Being the first successful online cryptography currency, Bitcoin has inspired other alternative currencies such as Litecoin, Peercoin, Primecoin, and so on.  The cryptocurrency then took off with the innovation of the turing-complete smart contract by Ethereum which led to the development of other amazing projects such as EOS, Tron, and even crypto-collectibles such as CryptoKitties.

Bitcoin

Bitcoin is trending as the crypto market experiences a broad liquidation event, triggering volatility and sparking debates about market manipulation and future price direction. Community discussions range from those anticipating further dips and shorting opportunities, to those who see this as a buying opportunity before an expected uptober. Several sources are discussing the possibility of a large move in either direction.

Ethereum is a global, open-source platform for decentralized applications. In other words, the vision is to create a world computer that anyone can build applications in a decentralized manner; while all states and data are distributed and publicly accessible. Ethereum supports smart contracts in which developers can write code in order to program digital value. Examples of decentralized apps (dapps) that are built on Ethereum includes tokens, non-fungible tokens, decentralized finance apps, lending protocol, decentralized exchanges, and much more.  On Ethereum, all transactions and smart contract executions require a small fee to be paid. This fee is called Gas. In technical terms, Gas refers to the unit of measure on the amount of computational effort required to execute an operation or a smart contract. The more complex the execution operation is, the more gas is required to fulfill that operation. Gas fees are paid entirely in Ether (ETH), which is the native coin of the blockchain. The price of gas can fluctuate from time to time depending on the network demand.

Ethereum

Ethereum is trending as the crypto market experiences volatility, leading to discussions about potential manipulation and strategic accumulation. Community members are actively debating whether to buy the dip or brace for further declines, while some point to the low exchange supply suggesting institutional accumulation. Broader market factors and the potential impact of upcoming upgrades are also being considered.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending due to Wedbush's increased price target and broader discussions around nuclear energy's role in powering AI data centers. The community is debating whether the stock is overvalued, with some pointing to insider selling and a lack of current revenue, while others highlight the potential of its technology and policy tailwinds. Discussions also mention Oklo breaking ground on its first Aurora Powerhouse, alongside a healthy dose of skepticism about its valuation.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending due to an analyst upgrade from BMO Capital despite lingering concerns around drug safety. Community members are weighing the potential for EU approval and discussing the implications of Roche's investor day, with some speculating on a possible buyout given Sarepta's undervalued status and promising pipeline. Bullish sentiment suggests anticipation of positive news and potential for significant price appreciation.

Snap, Inc. operates as a technology company, which engages in the provision of a visual messaging application that was created to help people communicate through short videos and images. The company was founded by Frank Reginald Brown IV, Evan Thomas Spiegel, and Robert C. Murphy in 2010 and is headquartered in Santa Monica, CA.

Snap Inc - Ordinary Shares - Class A

Snap Inc

Snap Inc. is trending amid renewed buyout speculation and potential benefits from TikTok's uncertain future, sparking a surge in trading volume and options activity. Community discussions revolve around possible acquisition scenarios, the value of Snap's user data, and the potential impact of its AR glasses technology. Some traders are also pointing to technical indicators suggesting a possible short squeeze.

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: House of Brands and Commercial and Wholesale. The House of Brands segment includes multiple categories including food and beverage, nutraceuticals, cannabis accessories and technology, personal care and wellness. The Commercial and Wholesale segment includes distribution of pharmaceutical products to international markets. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.

Flora Growth Corp

FLGC is trending following news of a distribution agreement and expansion into the THC-infused beverage market. Community members are discussing the company's potential in the cannabis sector, pointing to its low market cap and recent insider buying. Some traders are also highlighting technical indicators suggesting a possible breakout.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. is trending due to a $500 million private placement announcement, leading to community discussion about dilution and its potential impact on stock price.  While some investors are concerned about the company's valuation and cash burn, others remain optimistic about the long-term potential of quantum computing and QUBT's role in the sector, especially given the recent U.S.-U.K. collaboration efforts in quantum technology.

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Pfizer Inc.

Pfizer Inc

Pfizer is trending amid reports of a potential $7.3 billion acquisition of obesity drug developer Metsera, fueling discussions about its entry into the competitive weight loss market and potential impact on competitors. Some investors anticipate further acquisitions, particularly of Viking Therapeutics, while others express concern over vaccine-related controversies and their effect on Pfizer's stock.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is trending amid ongoing speculation about a potential acquisition, particularly after Pfizer's recent move to acquire Metsera. Community discussions revolve around Viking's valuation and potential as a buyout target, with some expressing frustration over management's strategy and others remaining confident in the company's pipeline and long-term prospects in the obesity and metabolic disease space.

Metsera, Inc. is a clinical stage biopharmaceutical company, which engages in the development of a next-generation injectable and oral nutrient stimulated hormone, or NuSH, analog peptides to treat obesity, overweight and related conditions. Its product pipeline includes MET-097i, MET-233, and MET-224o. The company was founded by Clive A. Meanwell on June 29, 2022 and is headquartered in New York, NY.

Metsera Inc.

Metsera Inc

Metsera (MTSR) is trending amid reports of a potential acquisition by Pfizer, driving community discussion around the valuation of obesity drug developers and speculation about future M&A activity in the biotech sector.  Traders are weighing the potential impact on other companies in the space, such as $VKTX and $ALT, as well as debating the merits of Metsera's pipeline and its competitive positioning against larger players like $LLY and $NVO.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

CynergisTek is a cybersecurity and privacy consulting firm focused on healthcare. CynergisTek offers an array of solutions that help organizations measure privacy and security programs against regulatory requirements and assists in developing a best practice approach to risk management. Since 2004 the company has served as a partner to hundreds of healthcare providers, payers and vendors with a consulting team comprised of subject matter experts that have a passion for helping clients achieve success. CynergisTek is also dedicated to supporting and educating the industry by contributing to relevant associations such as HIMSS, AHIMA, HFMA, HCCA, AHIA, AHLA, IAPP and CHIME.

Auxilio Inc

Just the one

Three

Four

The Fed just cut rates. How many cuts do you expect in all of 2025? 
 
*Powered by Polymarket

AUXO
Auxilio, Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest AUXO News

AUXO Auxilio, Inc.